Clearmind Medicine Stock (NASDAQ:CMND)


Chart

Previous Close

$1.03

52W Range

$0.80 - $2.18

50D Avg

$0.96

200D Avg

$1.20

Market Cap

$5.49M

Avg Vol (3M)

$874.75K

Beta

-1.28

Div Yield

-

CMND Company Profile


Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

4

IPO Date

Nov 15, 2022

Website

CMND Performance


Peer Comparison


TickerCompany
JFBRJeffs' Brands Ltd
ZVSAZyVersa Therapeutics, Inc.
SPRCSciSparc Ltd.
VRAXVirax Biolabs Group Limited
DRMADermata Therapeutics, Inc.